The Rio-based network of independent pharmacies blames drug industry intermediaries known as pharmacy benefit managers.

The US trade group Pharmaceutical Research and Manufacturers of America (PhRMA) today launched new advertisements urging ...

There is a tendency to overlook the multiple factors and stakeholders that contributed to the Rx opioid crisis. This includes ...

Through this partnership, Ibnsina Pharma aims to integrate more digital solutions into its distribution network, allowing pharmacists to access credit facilities directly via electronic payment system ...

CerpassRx, an independent pharmacy benefit manager, is teaming up with Waltz Health to launch a new AI-powered tool that aims ...

Dan Strause, co-founder, former CEO and current board chairman of Rio-based Hometown Pharmacy, said the low payments for drugs by pharmacy benefit ... for the Pharmaceutical Care Management ...

At Walgreens, a new management team is trying to reinvent the drugstore, but to hear them tell it, there’s a boogeyman ...

The rebate game played by drug makers and pharmacy benefit managers limits optimal biosimilar competition. As a result, U.S.

Third quarter 2024 figures of merit: Conference Call and Webcast The Company’s management ... realize the benefits of our ...

Kamen and Sequel Medtech CEO Alan Lotvin say they are offering greater precision in insulin delivery with new pump technology ...

A long-awaited report from the US Federal Trade Commission (FTC) on pharmacy benefit managers (PBMs) is out – and will make uncomfortable reading for the pharma supply chain middlemen.

Craig Hettenbach, an analyst from Morgan Stanley, maintained the Hold rating on GoodRx Holdings (GDRX – Research Report). The associated ...